Chronic pancreatitis represents a prevalent risk factor for the development of pancreatic cancer, thus necessitating more scrutiny of the association between GLP-1R agonists and the induction of chronic pancreatitis [67,68]. Here, GLP1R is linked to chronic pancreatitis.